EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three and 12 mon…
Category: Business
Zenni Optical Celebrates 25 Million Glasses Sold and Over 15 Years of Disrupting Industry-Controlled Pricing
NOVATO, Calif.–(BUSINESS WIRE)–Zenni Optical, the online optical industry leader, celebrates the company’s sweet 16 birthday with more than 25 million pairs of glasses sold. Zenni continues to see strong growth year-over-year and in 2018 alone, the o…
Vivior’s Produkt für CE-Kennzeichnung gemeldet – Markteinführung in Europa in diesem Jahr
ZÜRICH–(BUSINESS WIRE)–Vivior kann das von ihr entwickelte Produkt mit dem CE-Zeichen der Klasse I versehen und plant noch in diesem Jahr die Markteinführung in der Schweiz und der Europäischen Union. Vivior hat bei Swissmedic ihr Produkt, den «Visua…
Le système Vivior est homologué marquage CE – Introduction sur le marché européen cette année
ZURICH–(BUSINESS WIRE)–Vivior a homologué son système en tant que dispositif médical de classe I et prévoit son introduction sur le marché en Suisse et dans l’Union européenne plus tard cette année. Vivior a déclaré à Swissmedic son produit, le Visual Behavior Monitor, et satisfait à toutes les exigences d’un dispositif médical de classe I selon la directive sur les dispositifs médicaux (MDD). Grâce à cette étape importante, Vivior est maintenant autorisée à vendre son système en Suisse et da
Riassunto: Il sistema di Vivior è notificato per il marchio CE – Quest'anno il lancio sul mercato europeo
ZURIGO–(BUSINESS WIRE)–Vivior ha notificato suo sistema come dispositivo medico di Classe I e sta pianificando l’introduzione sul mercato quest’anno in Svizzera e nell’Unione Europea. Vivior ha informato Swissmedic del proprio prodotto, il Visual Behavior Monitor, che soddisfa tutti i requisiti di un dispositivo medico di Classe I secondo la Direttiva dei dispositivi medici (Medical Device Directive, MDD). Avendo raggiunto questo importante traguardo, ora Vivior può vendere il proprio sistema
Resumen: El sistema de Vivior ha sido aprobado para el marcado CE: este año se lanzará en el mercado europeo
ZÚRICH–(BUSINESS WIRE)–Vivior ha aprobado su sistema como un producto sanitario de Clase I y planea lanzarlo a finales de este año en Suiza y la Unión Europea. Vivior ha informado a Swissmedic sobre su producto, el Visual Behavior Monitor y, de acuer…
Blepharitis – 2019 Pipeline Insight Report: Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Blepharitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Blepharitis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indication
Retinal Vein Occlusion – Pipeline Insight, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Vein Occlusion – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Retinal Vein Occlusion development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage,
Vivior’s System Cleared for CE Mark – Market Introduction This Year in Europe
ZURICH–(BUSINESS WIRE)–Vivior has cleared their system as a Class I medical device and is planning the market introduction later this year in Switzerland and the European Union. Vivior has notified Swissmedic about their product, the Visual Behavior …
Compulink Previews New User Interface for its Ophthalmology SMART EHR at AAPOS 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink Previews New User Interface for its Ophthalmology SMART EHR at AAPOS 2019
Tangible Science Launches Tangible Clean, the Ideal Multi-Purpose Solution for Tangible Hydra-PEG Coated Lenses
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Tangible Science launches Tangible Clean, the ideal cleaning solution for Tangible Hydra-PEG coated gas permeable contact lenses.
Ocular Therapeutix™ Reports Election of Leslie Williams to Board of Directors
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
UnitedHealthcare Launches National Vision Laboratory Network Relationship with Essilor Labs
MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare has launched a national vision laboratory network relationship with Essilor Labs.
Compulink Previews New User Interface for its Optometry SMART EHR at Vision Expo East
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink previews new User Interface for its Optometry SMART EHR at this week’s Vision Expo East.
Ocular Therapeutix™ to Host 2019 Research & Development Day
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
SEODONG Medical推出创新干眼症治疗仪器，深受海外消费者好评
韩国 釜山–(BUSINESS WIRE)–SEODONG Medical推出创新干眼症治疗仪器 NURIEYE，深受海外消费者好评
Seodong Medical Launches Globally Recognized Innovative Device for Treating Dry Eye Syndrome
BUSAN, South Korea–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NURIEYE?src=hash" target="_blank"gt;#NURIEYElt;/agt;–Seodong Medical Launches Globally Recognized Innovative Device NURIEYE for Treating Dr…
DentalPlans.com Reminds Workers to Protect Their Eyes on The Job
PLANTATION, Fla.–(BUSINESS WIRE)–DentalPlans.com shares top eye safety tips for workers across the country in honor of Workplace Eye Wellness Month.
VisionCare, Inc. Announces Regulatory Approval of the CentraSight Treatment Program in Australia
SARATOGA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–VisionCare, Inc. announced that the Australian Department of Health Therapeutic Goods Administra…
Global Amblyopia Clinical Trials Review, H2, 2018 Featuring Herantis Pharma & Santen Pharmaceutical – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Amblyopia Global Clinical Trials Review, H2, 2018″ clinical trials has been added to ResearchAndMarkets.com’s offering. Amblyopia Global Clinical Trials Review, H2, 2018” provides an overview of Amblyopia clinical trials scenario. This report provides top line data relating to the clinical trials on Amblyopia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease